3-fluoro-5-hydroxybenzeneboronic acid
Product Information
Molecular Formula
C6H6BFO3
Molecular Weight
155.92
Description
3-fluoro-5-hydroxybenzeneboronic acid can serve as a catalyst for the synthesis of multiple drugs to advance cancer, diabetes, and inflammation research.
Synonyms
(3-fluoro-5-hydroxyphenyl)boronic acid; 3-FLUORO-5-HYDROXYBENZENEBORONIC ACID; (3-FLUORO-5-HYDROXY-PHENYL)BORONIC ACID; (3-fluoro-5-hydroxyphenyl)boronicacid; (3-fluoro-5-hydroxyphenyl)-boronic acid; SY007752; 3-FLUORO-5-HYDROXYPHENYLBORONICACID
IUPAC Name
(3-fluoro-5-hydroxyphenyl)boronic acid
SMILES
B(C1=CC(=CC(=C1)F)O)(O)O
InChI
InChI=1S/C6H6BFO3/c8-5-1-4(7(10)11)2-6(9)3-5/h1-3,9-11H
InChI Key
RMBFBZIEXCTPDB-UHFFFAOYSA-N
Flash Point
Not applicable
Computed Properties
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
1
Exact Mass
156.0394024 g/mol
Monoisotopic Mass
156.0394024 g/mol
Topological Polar Surface Area
60.7Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
133
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| CN-113058646-A | Heterogeneous hindered Lewis acid-base pair catalyst and preparation method and application thereof | 2021-03-26 |
| CN-112574224-A | KRAS G12C inhibitor and application thereof | 2019-09-30 |
| WO-2021063346-A1 | Kras g12c inhibitor and application thereof | 2019-09-30 |
| US-2021077385-A1 | Wet-packed soft hydrogel ocular inserts | 2019-09-18 |
| WO-2021053586-A1 | Wet-packed soft hydrogel ocular inserts | 2019-09-18 |
| TW-202114636-A | Wet-packed soft hydrogel ocular inserts | 2019-09-18 |
| WO-2020123395-A1 | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors | 2018-12-10 |
| TW-202039487-A | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors | 2018-12-10 |
| AU-2019395338-A1 | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors | 2018-12-10 |
| BR-112021010842-A2 | 2-Oxoquinazoline Derivatives as Methionine Adenosyltransferase 2a Inhibitors | 2018-12-10 |
